Association of Catechol-O-Methyltransferase Polymorphism (Val108/158Met) With Parkinson's Disease: A Meta-Analysis

REFERENCES

• Bialecka , M. , Drozdzik , M. , Honczarenko , K. , Gawrońska-Szklarz , B. , Stankiewicz , J. Dabrowska , E. 2005 . Catechol-O-methyltransferase and monoamine oxidase B genes and susceptibility to sporadic Parkinson's disease in a Polish population . European Neurology , 53 : 68 – 73 .
   Web of Science ®Google Scholar
• Bialecka , M. , Klodowska-Duda , G. , Honczarenko , K. and Gawrońska-Szklarz . 2007 . Polymorphisms of catechol-0-methyltransferase (COMT), monoamine oxidase B (MAOB), N-acetyltransferase 2 (NAT2) and cytochrome P450 2D6 (CYP2D6) gene in patients with early onset of Parkinson's disease . Parkinsonism and Related Disorders , 13 : 224 – 229 .
   PubMed Web of Science ®Google Scholar
• Bialecka , M. , Kurzawski , M. , Klodowska-Duda , G. , Opala , G. , Tan , E. K. and Drozdzik , M. 2008 . The association of functional catechol-O-methyltransferase haplotypes with risk of Parkinson's disease, levodopa treatment response, and complications . Pharmacogenetics and Genomics , 18 : 815 – 821 .
   PubMed Web of Science ®Google Scholar
• Bonifacio , M. J. , Palma , P. N. , Almeida , L. and Soares-da-Silva , P. 2007 . Catechol-O-methyltransferase and its inhibitors in Parkinson's disease . CNS Drug Reviews , 13 : 352 – 379 .
   PubMedGoogle Scholar
• Chen , J. , Lipska , B. K. , Halim , N. , Ma , Q. D. , Matsumoto , M. Melhem , S. 2004 . Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): Effects on mRNA, protein, and enzyme activity in postmortem human brain . The American Journal of Human Genetics , 75 : 807 – 821 .
   PubMed Web of Science ®Google Scholar
• Chikako , K. , Yoshihiro , M. , Midori , K. , Takahiro , F. , Senji , S. Keiko , T. 2011 . Genetic polymorphisms involved in dopaminergic neurotransmission and risk for Parkinson's disease in a Japanese population . BMC Neurology , 11 : 89
   Web of Science ®Google Scholar
• Cochran , W. G. 1954 . The combination of estimates from different experiments . Biometrics , 10 : 101 – 29 .
   Web of Science ®Google Scholar
• Dai , H. , Yuan , F. Y. , Shao , M. , Wang , Y. J. and Chen , Y. D. 2005 . Association between polymorphism of COMT gene and motor fluctuation induced by levodopa in Parkinson's disease . Chinese Journal of Geriatric Cardiovascular and Cerebrovascular Diseases , 7 : 178 – 180 .
   Google Scholar
• De Lau , L. M. and Breteler , M. M. 2006 . Epidemiology of Parkinson's disease . Lancet Neurology , 5 : 525 – 35 .
   PubMed Web of Science ®Google Scholar
• Eerola , J. , Launes , J. , Hellström , O. and Tienari , P. J. 2002 . Apolipoprotein E (APOE), PARKIN and catechol-O-methyltransferase (COMT) genes and susceptibility to sporadic Parkinson's disease in Finland . Neuroscience Letters , 330 : 296 – 298 .
   PubMed Web of Science ®Google Scholar
• Ehrlich , S. , Morrow , E. M. , Roffman , J. L. , Wallace , S. R. , Naylor , M. Bockholt , H. J. 2010 . The COMT Val108/158Met polymorphism and medial temporal lobe volumetry in patients with schizophrenia and healthy adults . Neuroimage , 53 : 992 – 1000 .
   PubMed Web of Science ®Google Scholar
• Foltynie , T. , Goldberg , T. E. , Lewis , S. G. , Blackwell , A. D. , Kolachana , B. S. Weinberger , D. R. 2004 . Planning ability in Parkinson's disease is influenced by the COMT val158met polymorphism . Movement Disorders , 19 : 885 – 891 .
   PubMed Web of Science ®Google Scholar
• Gibb , W. R. and Lees , A. J. 1988 . The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease . Journal of Neurology, Neurosurgery & Psychiatry , 51 : 745 – 752 .
   PubMed Web of Science ®Google Scholar
• Golbe , L. I. , Lazzarini , A. M. , Spychala , J. R. , Johnson , W. G. , Stenroos , E. S. , Mark , M. H. and Sage , J. I. 2001 . The Tau A0 allele in Parkinson's disease . Movement Disorders , 16 : 442 – 447 .
   PubMed Web of Science ®Google Scholar
• Goudreau , J. L. , Maraganore , D. M. , Farrer , M. J. , Lesnick , T. G. , Singleton , A. B. Bower , J. H. 2002 . Case-control study of dopamine transporter-1, monoamine oxidase-B, and catechol-O-methyl transferase polymorphisms in Parkinson's disease . Movement Disorders , 17 : 1305 – 1311 .
   PubMed Web of Science ®Google Scholar
• Hao , M. , Liu , Z. L. , Tao , E. X. and Chen , B. 2005 . Correlation between the genetic polymorphism of dopamine metabolic enzymes and the genetic susceptibility of Parkinson's disease . Chinese Journal of Gerontology , 25 : 743 – 745 .
   Google Scholar
• Harbord , R. M. , Egger , M. and Sterne , J. A. 2006 . A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints . Statistics in Medicine , 25 : 3443 – 3457 .
   PubMed Web of Science ®Google Scholar
• Hernan , M. A. , Checkoway , H. O. , Brien , R. , Costa-Mallen , P. , De Vivo , I. Colditz , G. A. 2002 . MAOB intron 13 and COMT codon 158 polymorphisms, cigarette smoking, and the risk of PD . Neurology , 58 : 1381 – 1387 .
   PubMed Web of Science ®Google Scholar
• Hoda , F. , Nicholl , D. , Bennett , P. , Arranz , M. , Aitchison , K. J. Chalabi , A. 1996 . No association between Parkinson's disease and low-activity alleles of catechol O-methyltransferase . Biochemical and Biophysical Research Communications , 228 : 780 – 784 .
   PubMed Web of Science ®Google Scholar
• Higgins , J. P. and Thompson , S. G. 2002 . Quantifying heterogeneity in a meta-analysis . Statistics in Medicine , 21 : 1539 – 1558 .
   PubMed Web of Science ®Google Scholar
• Kalinderi , K. , Fidani , L. , Kourtesi , G. , Katsarou , Z. , Mioglou , E. and Bostantjopoulou , S. 2008 . No association of the Val158Met COMT polymorphism with Parkinson's disease in the Greek population . European Journal of Neurology , 15 : e83
   PubMed Web of Science ®Google Scholar
• Kunugi , H. , Nanko , S. , Ueki , A. , Otsuka , E. , Hattori , M. Hoda , F. 1997 . High and low activity alleles of catechol-O-methyltransferase gene: ethnic difference and possible association with Parkinson's disease . Neuroscience Letters , 221 : 202 – 204 .
   PubMed Web of Science ®Google Scholar
• Lee , C. G. , Tang , K. , Cheung , Y. B. , Wong , L. P. , Tan , C. Shen , H. 2004 . MDR1, the blood-brain barrier transporter, is associated with Parkinson's disease in ethnic Chinese . Journal of Medical Genetics , 41 : e60
   Web of Science ®Google Scholar
• Lee , M. S. , Lyoo , C. H. , Ulmanen , I. , Syvanen , A. C. and Rinne , J. O. 2001 . Genotypes of catechol-O-methyltransferase and response to levodopa treatment in patients with Parkinson's disease . Neuroscience Letters , 298 : 131 – 134 .
   PubMed Web of Science ®Google Scholar
• Lesage , S. and Brice , A. 2009 . Parkinson's disease: from monogenic forms to genetic susceptibility factors . Human Molecular Genetics , 18 : R48 – 59 .
   PubMed Web of Science ®Google Scholar
• Lewis , D. A. , Melchitzky , D. S. , Sesack , S. R. , Whitehead , R. E. , Auh , S. and Sampson , A. 2001 . Dopamine transporter immunoreactivity in monkey cerebral cortex: regional, laminar, and ultrastructural localization . The Journal of Comparative Neurology , 432 : 119 – 136 .
   PubMed Web of Science ®Google Scholar
• Lynch , D. R. , Mozley , P. D. , Sokol , S. , Maas , N. M. , Balcer , L. J. and Siderowf , A. D. 2003 . Lack of effect of polymorphisms in dopamine metabolism related genes on imaging of TRODAT-1 in striatum of asymptomatic volunteers and patients with Parkinson's disease . Movement Disorders , 18 : 804 – 812 .
   PubMed Web of Science ®Google Scholar
• Mantel , N. and Haenszel , W. 1959 . Statistical aspects of the analysis of data from retrospective studies of disease . Journal of the National cancer Institute , 22 : 719 – 748 .
   PubMed Web of Science ®Google Scholar
• Maraganore , D. M. , Lesnick , T. G. , Elhaz , A. , Chartier-Harlin , M.-C. , Gasser , T. Kruger , R. 2004 . UCHL1 is a Parkinson's disease susceptibility gene . Annals of Neurology , 55 : 512 – 521 .
   PubMed Web of Science ®Google Scholar
• Mizuta , I. , Mizuta , E. , Yamasaki , S. , Kuno , S. , Yasuda , M. and Tanaka , C. 2000 . Meta-analysis of polymorphism of the catechol-O-methyltransferase gene in relation to the etiology of Parkinson's disease in Japan . Movement Disorders , 15 : 1013 – 1014 .
   PubMed Web of Science ®Google Scholar
• Nedic , G. , Nikolac , M. , Sviglin , K. N. , Muck-Seler , D. , Borovecki , F. and Pivac , N. 2011 . Association study of a functional catechol-O-methyltransferase (COMT) Val108/158Met polymorphism and suicide attempts in patients with alcohol dependence . International Journal of Neuropsych Opharmacology , 14 : 377 – 388 .
   Web of Science ®Google Scholar
• Nuytemans , K. , Theuns , J. , Cruts , M. and Van Broeckhoven , C. 2010 . Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: A mutation update . Human Mutation , 31 : 763 – 780 .
   PubMed Web of Science ®Google Scholar
• Obeso , J. A. , Rodriguez-Oroz , M. C. , Benitez-Temino , B. , Blesa , F. J. , Guridi , J. , Marin , C. and Rodriguez , M. 2008 . Functional organization of the basal ganglia: therapeutic implications for Parkinson's disease . Movement Disorders , 23 : S548 – 559 .
   PubMed Web of Science ®Google Scholar
• Pivac , N. , Pregelj , P. , Nikolac , M. , Zupanc , T. , Nedic , G. , Muck Seler , D. and Videtic Paska , A. 2011 . The association between catechol-O-methyl-transferase Val108/158Met polymorphism and suicide . Genes, Brain and Behavior, 10 , : 565 – 569 .
   Google Scholar
• Samii , A. , Nutt , J. G. and Ransom , B. R. 2004 . Parkinson's disease . The Lancet , 363 ( 9423 ) : 1783 – 1793 .
   PubMed Web of Science ®Google Scholar
• Shao , M. , Liu , Z. L. , Tao , E. X. and Chen , B. 2000 . Relation between the genetic polymorphism catechol-O-methyltransferase gene and susceptibility of Parkinson's disease . Chinese Journal of Neurology , 33 : 17 – 19 .
   Google Scholar
• Shao , M. , Liu , Z. L. , Tao , E. X. and Chen , B. 2001 . Correlation between the genetic polymorphism of dopamine metabolic enzymes and the genetic susceptibility of Parkinson's disease . Chinese Journal of Gerontology , 7 : 743 – 745 .
   Google Scholar
• Shield , A. J. , Thomae , B. A. , Eckloff , B. W. , Wieben , E. D. and Weinshilboum , R. M. 2004 . Human catechol O-methyltransferase genetic variation: gene resequencing and functional characterization of variant allozymes . Molecular Psychiatry , 9 : 151 – 160 .
   PubMed Web of Science ®Google Scholar
• Syvanen , A. C. , Tilgmann , C. , Rhine , J. and Ulmanen , I. 1997 . Genetic polymorphism of catechol-O-methyltransferase (COMT): Correlation of genotype with individual variation of S-COMT activity and comparison of the allele frequencies in the normal population and Parkinsonian patients in Finland . Pharmacogenetics and Genomics , 7 : 65 – 71 .
   Google Scholar
• Tan , E. K. , Chai , A. , Lum , S. Y. , Shen , H. , Tan , C. Teoh , M. L. 2003 . Monoamine oxidase B polymorphism, cigarette smoking and risk of Parkinson's disease: A study in an Asian population . American Journal of Medical Genetics Part B: Neuropsychiatric Genetics , 120 : 58 – 62 .
   Google Scholar
• Tan , E. K. , Chai , A. , Teo , Y. Y. , Zhao , Y. , Tan , C. Shen , H. 2004 . Alpha-synuclein haplotypes implicated in risk of Parkinson's disease . Neurology , 62 : 128 – 131 .
   PubMed Web of Science ®Google Scholar
• Tan , E. K. , Khajavi , M. , Thornby , J. I. , Nagamitsu , S. , Jankovic , J. and Ashizawa , T. 2000 . Variability and validity of polymorphism association studies in Parkinson's disease . Neurology , 55 : 533 – 538 .
   PubMed Web of Science ®Google Scholar
• Watanabe , M. , Harada , S. , Nakamura , T. , Ohkoshi , N. , Yoshizawa , K. , Hayashi , A. and Shoji , S. 2003 . Association between catechol-O-methyltransferase gene polymorphisms and wearing-off and dyskinesia in Parkinson's disease . Neuropsychobiology , 48 : 190 – 193 .
   PubMed Web of Science ®Google Scholar
• Williams-Gray , C. H. , Hampshire , A. , Barker , R. A. and Owen , A. M. 2008 . Attentional control in Parkinson's disease is dependent on COMT val 158 met genotype . Brain , 131 : 397 – 408 .
   PubMed Web of Science ®Google Scholar
• Wu , R. M. , Cheng , C. W. , Chen , K. H. , Lu , S. L. , Shan , D. E. , Ho , Y. F. and Chern , H. D. 2001 . The COMT L allele modifies the association between MAOB polymorphism and PD in Taiwanese . Neurology , 56 : 375 – 382 .
   PubMed Web of Science ®Google Scholar
• Xie , T. , Ho , S. L. , Li , L. S. and Ma , O. C. 1997 . G/A1947 polymorphism in catechol-O-methyltransferase (COMT) gene in Parkinson's disease . Movement Disorders , 12 : 426 – 427 .
   PubMed Web of Science ®Google Scholar
• Xu , L. , Hao , Y. X. , Xie , H. J. , Tang , G. M. and Ren , D. M. 2002 . Association between polymorphism of catechol-o-methyltransferase gene G/A and Parkinson's Disease among Chinese Han in Shanghai . Chinese Journal of Medical Genetics , 22 : 440 – 441 .
   Google Scholar
• Yoritaka , A. , Hattori , N. , Yoshino , H. and Mizuno , Y. 1997 . Catechol-O-methyltransferase genotype and susceptibility to Parkinson's disease in Japan . Journal of Neural Transmission , 104 : 1313 – 1317 .
   PubMed Web of Science ®Google Scholar
• Zhao , X. P. , Xie , H. J. , Tang , G. M. , Zhao , W. W. , Xu , L. , Lin , D. Y. , Zhu , Q. Q. , Su , J. J. , Han , H. X. , Hao , Y. X. , Lan , H. K. , Wang , Y. Y. and Ren , D. M. 2003 . Association between four genes involved in dopaminergic neurotransmitter metabolic COMT, DBH, DAT1, MAOB and susceptible to Parkinson's disease in Shanghai Hans . Chinese Journal of Clinical Rehabilitation , 7 : 1126 – 1127 .
   Google Scholar
• Zhao , X. P. , Xu , T. , Zhang , W. W. , Xie , H. J. , Li , L. and Zheng , H. M. 2005 . Synergistic role of polymorphism of dopamine beta hydroxylase gene and catechol-o-methyltransferase gene in genetic susceptibility to Parkinson disease . Chinese Journal of Clinical Rehabilitation , 9 : 45 – 47 .
   Google Scholar